Sulfasalazine in pregnancy to change stress hormone levels
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This Phase 2 study tests whether sulfasalazine, a medicine taken by mouth, can lower a pregnancy stress hormone called CRH in pregnant people. It’s aimed at people at higher risk for preterm birth, to see if the hormone change might be helpful.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be older than 18 years
- You must be pregnant with one baby (singleton pregnancy)
- You must be between 12 and 22 weeks pregnant
- You must have had a preterm birth in a previous pregnancy
- Your pregnancy due dates must be confirmed by ultrasound
- You must be able and willing to swallow the study capsules as instructed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how stress shows up in the body during early pregnancy and whether it’s linked to preterm birth (birth before 37 weeks). You may be asked about your stress and health to help researchers understand who is at higher risk.
This study tests a lifestyle coaching program to help reduce stress and improve emotional wellbeing during pregnancy. It may help lower risks for the baby by supporting healthier daily routines and mental health.
This Phase 2 study tests whether starting low-dose aspirin after delivery can help people who had severe preeclampsia. The goal is to see if this treatment is safe and beneficial in the weeks after birth.
This study tests whether taking a low dose of aspirin early in pregnancy can lower the risk of losing the baby or developing preeclampsia (a serious condition with high blood pressure). It is for women who have risk factors for these problems and are very early in pregnancy (less than 7 weeks).
This study tests whether taking a low dose of aspirin along with a stomach-protecting medicine (lansoprazole) can help prevent early birth in pregnant women who are at higher risk. It may reduce the chance of having your baby too early, which can be better for your baby's health.
This Phase 1 study looks at a treatment plan for people with systemic lupus (SLE) during pregnancy and tracks health outcomes for mother and baby. It may help doctors learn how to manage SLE safely in pregnancy and what results to expect.
Hear when a new Preterm Birth trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.